R&D | April 17, 2026
Revvity aims to accelerate breakthroughs in cancer research
Revvity is positioning its technologies as a connected engine for discovery
Revvity is positioning its technologies as a connected engine for discovery
New purpose-built AI model targets faster R&D cycles and deeper scientific insights across life sciences
American College of Cardiology and Korean Society of Cardiology convene global experts to address rising cardiometabolic burden
he innovation could pave the way for early and low-cost screening of smoking exposure and second-hand smoke biomarkers
The collaboration combines Alveus’ expertise in metabolic biology and therapeutic strategy with Aurigene’s integrated discovery capabilities
The CE Mark builds on the company’s ISO 13485 certification, further strengthening confidence in the platform's safety, quality and performance
The upcoming multi-center, multinational Phase 1 study will evaluate safety, tolerability, pharmacokinetics, and early signs of efficacy
Strategic expansion strengthens CDMO’s support for biotech and pharma innovators across the Asia-Pacific region
Arcot is a seasoned executive with more than two decades of experience across the global pharma and life sciences sectors
The ninth edition of the event brought together over 800 delegates, more than 60 national and international speakers, and 20+ partner organisations across 10 sessions
Subscribe To Our Newsletter & Stay Updated
